MiR-21 is highly expressed in the serum of patients with NSCLC, whereas its depletion reduces A549 cell proliferation, migration, and invasion by up-regulating programmed cell death protein 4 (PDCD4) expression [51]. The gene discussed is PDCD4; the disease is non-small cell lung carcinoma.